The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
FIBROGEN ORD | COM | 31572Q808 | 12,537 | 277,500 | SH | Call | SOLE | 277,500 | 0 | 0 | |
ASSEMBLY BIOSCIENCES ORD | COM | 045396108 | 3,721 | 275,800 | SH | Call | SOLE | 275,800 | 0 | 0 | |
ASSEMBLY BIOSCIENCES ORD | COM | 045396108 | 3,002 | 222,500 | SH | Call | SOLE | 222,500 | 0 | 0 | |
KURA ONCOLOGY ORD | COM | 50127T109 | 103,899 | 5,276,753 | SH | SOLE | 5,276,753 | 0 | 0 | ||
XENCOR ORD | COM | 98401F105 | 95,635 | 2,336,557 | SH | SOLE | 2,336,557 | 0 | 0 | ||
CRISPR THERAPEUTICS ORD | COM | H17182108 | 75,843 | 1,610,250 | SH | SOLE | 1,610,250 | 0 | 0 | ||
FIBROGEN ORD | COM | 31572Q808 | 68,302 | 1,511,785 | SH | SOLE | 1,511,785 | 0 | 0 | ||
SPARK THERAPEUTICS ORD | COM | 84652J103 | 62,874 | 614,128 | SH | SOLE | 614,128 | 0 | 0 | ||
MIRATI THERAPEUTICS ORD | COM | 60468T105 | 61,564 | 597,711 | SH | SOLE | 597,711 | 0 | 0 | ||
DICERNA PHARMACEUTICALS ORD | COM | 253031108 | 52,233 | 3,316,407 | SH | SOLE | 3,316,407 | 0 | 0 | ||
IRONWOOD PHARMA CL A ORD | COM | 46333X108 | 51,105 | 4,671,408 | SH | SOLE | 4,671,408 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL ORD | COM | 90400D108 | 31,617 | 497,899 | SH | SOLE | 497,899 | 0 | 0 | ||
CHIASMA ORD | COM | 16706W102 | 22,737 | 3,043,827 | SH | SOLE | 3,043,827 | 0 | 0 | ||
MORPHIC HOLDING ORD | COM | 61775R105 | 44,928 | 2,266,804 | SH | SOLE | 947,618 | 0 | 0 | ||
HARPOON THERAPEUTICS ORD | COM | 41358P106 | 17,529 | 1,348,423 | SH | SOLE | 1,348,423 | 0 | 0 | ||
ATRECA CL A ORD | COM | 04965G109 | 28,015 | 1,486,979 | SH | SOLE | 771,672 | 0 | 0 | ||
ARQULE ORD | COM | 04269E107 | 14,313 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
EIGER BIOPHARMACEUTICAL ORD | COM | 28249U105 | 12,042 | 1,136,043 | SH | SOLE | 1,136,043 | 0 | 0 | ||
ARCUS BIOSCIENCES ORD | COM | 03969F109 | 11,787 | 1,488,205 | SH | SOLE | 1,488,205 | 0 | 0 | ||
PREVAIL THERAPEUTICS ORD | COM | 74140Y101 | 31,582 | 2,392,556 | SH | SOLE | 838,235 | 0 | 0 | ||
UNITY BIOTECHNOLOGY ORD | COM | 91381U101 | 9,923 | 1,044,500 | SH | SOLE | 1,044,500 | 0 | 0 | ||
PROTHENA ORD | COM | G72800108 | 7,645 | 723,300 | SH | SOLE | 723,300 | 0 | 0 | ||
RUBIUS THERAPEUTICS ORD | COM | 78116T103 | 7,285 | 463,152 | SH | SOLE | 463,152 | 0 | 0 | ||
SURFACE ONCOLOGY ORD | COM | 86877M209 | 6,522 | 2,312,688 | SH | SOLE | 2,312,688 | 0 | 0 | ||
MERSANA THERAPEUTICS ORD | COM | 59045L106 | 5,639 | 1,392,231 | SH | SOLE | 1,392,231 | 0 | 0 | ||
CURIS ORD | COM | 231269200 | 5,547 | 2,982,208 | SH | SOLE | 2,982,208 | 0 | 0 | ||
AQUINOX PHARMACEUTICALS ORD | COM | 03842B101 | 5,347 | 2,265,880 | SH | SOLE | 2,265,880 | 0 | 0 | ||
CYCLERION THERAPEUTICS ORD | COM | 23255M105 | 8,888 | 776,206 | SH | SOLE | 438,572 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS ORD | COM | 76243J105 | 4,910 | 223,167 | SH | SOLE | 223,167 | 0 | 0 | ||
SOLID BIOSCIENCES ORD | COM | 83422E105 | 4,755 | 827,000 | SH | SOLE | 827,000 | 0 | 0 | ||
NGM BIOPHARMACEUTICALS ORD | COM | 62921N105 | 4,639 | 316,900 | SH | SOLE | 316,900 | 0 | 0 | ||
KEZAR LIFE SCIENCES ORD | COM | 49372L100 | 4,497 | 583,293 | SH | SOLE | 583,293 | 0 | 0 | ||
ADURO BIOTECH ORD | COM | 00739L101 | 2,713 | 1,761,421 | SH | SOLE | 1,761,421 | 0 | 0 | ||
VERICEL ORD | COM | 92346J108 | 2,475 | 131,001 | SH | SOLE | 131,001 | 0 | 0 | ||
SYROS PHARMACEUTICALS ORD | COM | 87184Q107 | 2,301 | 248,480 | SH | SOLE | 248,480 | 0 | 0 | ||
GAMIDA CELL ORD | COM | M47364100 | 265 | 52,120 | SH | SOLE | 52,120 | 0 | 0 | ||
TCR2 THERAPEUTICS ORD | COM | 87808K106 | 231 | 16,114 | SH | SOLE | 16,114 | 0 | 0 | ||
ARGENX ADR REP ORD | SPONSORED ADR | 04016X101 | 82,281 | 581,165 | SH | SOLE | 581,165 | 0 | 0 | ||
REGULUS THERAPEUTICS | COM | 75915K200 | 1,389 | 1,111,110 | SH | SOLE | 1,111,110 | 0 | 0 | ||
GOSSAMER BIO INC ORD | COM | 38341P102 | 17,125 | 772,096 | SH | SOLE | 772,096 | 0 | 0 |